AHR

$53.521.10%0.58

American Healthcare Reit Inc (AHR)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$52.94

Aprire:

$53.47

Volume 24 ore:

2,911,396

Volume relativo:

0.86

Capitalizzazione di mercato:

$11.67B

Reddito:

$2.37B

Utile/perdita netta:

$101.67M

Rapporto P/E:

92.68

EPS:

$0.5775

Flusso di cassa netto:

$169.19M

1W Prestazione:

-0.06%

1M Prestazione:

+5.46%

6M Prestazione:

+6.72%

1Y Prestazione:

+18.09%

Intervallo 1D:

$0.00$0.00

Intervallo di 1 settimana:

$49.38$54.20

Portata 52W:

$44.41$58.70

Profilo aziendale di American Healthcare Reit Inc (AHR)

Nome

American Healthcare Reit Inc

Settore

Real Estate

Industria

REIT - Healthcare Facilities

Telefono

949-270-9200

Indirizzo

18191 VON KARMAN AVENUE, IRVINE, USA

Dipendente

121

Prossima data di guadagno

2026-11-05

Ultimi documenti SEC

SEC

Discussioni di AHR su X

Confronta AHR con WELL, VTR, OHI, DOC

Azioni	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AHR American Healthcare Reit Inc	$11.67B	$2.37B	$101.67M	$169.19M	$0.5775
WELL Welltower Inc	$172.10B	$11.75B	$1.46B	$2.19B	-$0.6014
VTR Ventas Inc	$44.84B	$6.13B	$272.21M	$1.38B	$0.5521
OHI Omega Healthcare Investors Inc	$14.24B	$1.24B	$655.98M	$857.80M	$2.06
DOC Healthpeak Properties Inc	$13.12B	$2.87B	$250.10M	$1.13B	$0.3188

American Healthcare Reit Inc Azioni (AHR) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-10-13	Iniziato	Raymond James	Strong Buy
2026-07-21	Iniziato	Compass Point	Buy
2026-07-07	Iniziato	Barclays	Overweight
2026-06-23	Aggiornamento	Citigroup	Neutral → Buy
2026-01-29	Iniziato	BMO Capital Markets	Outperform
2025-09-19	Iniziato	UBS	Buy
2025-07-18	Iniziato	Robert W. Baird	Outperform
2025-06-30	Iniziato	Scotiabank	Sector Outperform
2025-04-28	Iniziato	Jefferies	Buy
2024-03-14	Iniziato	Barclays	Overweight
2024-03-04	Iniziato	BofA Securities	Buy
2024-03-04	Iniziato	Citigroup	Neutral
2024-03-04	Iniziato	JMP Securities	Mkt Outperform
2024-03-04	Iniziato	KeyBanc Capital Markets	Overweight
2024-03-04	Iniziato	Morgan Stanley	Overweight
2024-03-04	Iniziato	RBC Capital Mkts	Outperform
2024-03-04	Iniziato	Truist	Buy

American Healthcare Reit Inc Azioni (AHR) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	2,260.12	1,883.80	1,668.74	1,412.16	1,123.94
Cost of revenue USD (M)	1,793.53	1,653.89	1,502.31	1,281.53	1,030.19
Operating expenses USD (M)	2,096.36	1,941.02	1,795.69	1,556.97	1,258.33
Operating income USD (M)	415.16	363.54	306.83	301.97	213.34
Income before tax USD (M)	48.65	-33.89	-76.22	-72.80	-52.31
Income tax expense USD (M)	-22.17	1.71	0.66	0.59	0.96
Net income USD (M)	70.82	-35.60	-76.89	-73.38	-53.27
Basic EPS USD/shares	0.42	-0.29	-1.08	-1.24	-0.24
Diluted EPS USD/shares	0.42	-0.29	-1.08	-1.24	-0.24
Basic weighted shares shares (M)	166.06	130.64	66.05	65.81	200.32
Diluted weighted shares shares (M)	166.85	130.64	66.05	65.81	200.32

American Healthcare Reit Inc Azioni (AHR) insider trading

Mark FosterSep 25 '26
Officer
Transazione
Proposed Sale
Costo
$52.06
#Azioni
1,500
Valore ($)
78,090
#Azioni Totale
0
Mark FosterSep 01 '26
Officer
Transazione
Proposed Sale
Costo
$55.39
#Azioni
2,000
Valore ($)
110,780
#Azioni Totale
0
Foster Mark E.Sep 01 '26
EVP, GC & Secretary
Transazione
Sale
Costo
$55.39
#Azioni
2,000
Valore ($)
110,780
#Azioni Totale
51,617
Brian PeayJun 26 '26
Officer
Transazione
Proposed Sale
Costo
$50.70
#Azioni
25,000
Valore ($)
1,267,404
#Azioni Totale
0
PEAY BRIANJun 26 '26
Chief Financial Officer
Transazione
Sale
Costo
$50.70
#Azioni
25,000
Valore ($)
1,267,402
#Azioni Totale
152,700
Foster Mark E.Jun 24 '26
EVP, GC & Secretary
Transazione
Sale
Costo
$48.58
#Azioni
2,500
Valore ($)
121,450
#Azioni Totale
52,995
Mark FosterJun 24 '26
Officer
Transazione
Proposed Sale
Costo
$48.58
#Azioni
2,500
Valore ($)
121,450
#Azioni Totale
0
Foster Mark E.Jun 01 '26
EVP, GC & Secretary
Transazione
Sale
Costo
$48.32
#Azioni
2,000
Valore ($)
96,640
#Azioni Totale
55,495
Mark FosterJun 01 '26
officer
Transazione
Proposed Sale
Costo
$48.32
#Azioni
2,000
Valore ($)
96,640
#Azioni Totale
0
Foster Mark E.Mar 25 '26
EVP, GC & Secretary
Transazione
Sale
Costo
$48.55
#Azioni
2,000
Valore ($)
97,100
#Azioni Totale
56,121

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Mark Foster	Officer	Sep 25 '26	Proposed Sale	$52.06	1,500	78,090	0
Mark Foster	Officer	Sep 01 '26	Proposed Sale	$55.39	2,000	110,780	0
Foster Mark E.	EVP, GC & Secretary	Sep 01 '26	Sale	$55.39	2,000	110,780	51,617
Brian Peay	Officer	Jun 26 '26	Proposed Sale	$50.70	25,000	1,267,404	0
PEAY BRIAN	Chief Financial Officer	Jun 26 '26	Sale	$50.70	25,000	1,267,402	152,700
Foster Mark E.	EVP, GC & Secretary	Jun 24 '26	Sale	$48.58	2,500	121,450	52,995
Mark Foster	Officer	Jun 24 '26	Proposed Sale	$48.58	2,500	121,450	0
Foster Mark E.	EVP, GC & Secretary	Jun 01 '26	Sale	$48.32	2,000	96,640	55,495
Mark Foster	officer	Jun 01 '26	Proposed Sale	$48.32	2,000	96,640	0
Foster Mark E.	EVP, GC & Secretary	Mar 25 '26	Sale	$48.55	2,000	97,100	56,121

American Healthcare Reit Inc Borsa (AHR) Ultime notizie

Oct 29, 2026

CubeSmart (CUBE) Surpasses Q3 FFO and Revenue Estimates - Zacks Investment Research

Oct 29, 2026

SBA Communications to Report Q3 Earnings: What to Expect From SBAC? - Zacks Investment Research

Oct 29, 2026

Oct 27, 2026

American Healthcare REIT Falls as Higher Yields and Equity Overhang Likely Weigh on Shares - Quiver Quantitative

Oct 27, 2026

American Healthcare REIT (NYSE:AHR) Stock Price Breaks Above 50-Day Moving Average - Here's What Happened - MarketBeat

Oct 27, 2026

Oct 25, 2026

American Healthcare REIT, Inc. Estimates – BMV:AHR - TradingView

Oct 25, 2026

Oct 24, 2026